Global Arbovirus Testing Market Expected to Reach USD 4.67 Billion by 2031 Due to Outbreak Preparedness and Diagnostic Innovation

[Geneva, 5th June 2025] - Clearview Market Insights (CVMI) forecasts that the global arbovirus testing market will grow from USD 1.84 billion in 2024 to USD 4.67 billion by 2031, achieving a robust compound annual growth rate (CAGR) of 14.2 percent. This expansion is driven by an increase in vector-borne disease outbreaks, heightened investment in public health surveillance, and rapid advancements in field-deployable diagnostics.

"Arbovirus testing is no longer seasonal or regional-it's a core component of global outbreak intelligence and pandemic prevention," said Dr. Martin Alvarez, infectious disease diagnostics lead at CVMI. "The convergence of AI, mobile diagnostics, and next-gen serology is transforming how health systems detect, report, and respond to vector-borne threats."

Request Sample @ https://clearviewmarketinsights.com/report-details/global-arbovirus-testing-market/

Key Numbers:
• 2024 Market Value: USD 1.84 billion
• 2031 Market Value: USD 4.67 billion
• Seven-Year CAGR: 14.2 percent
• Dengue Testing Share (2024): 41%
• Asia-Pacific Market Share: 39%

Market Drivers:
• Climate-driven spread of mosquitoes and ticks
• Global health funding for early detection
• Urban travel and international disease transmission
• WHO, CDC, and PAHO-led surveillance initiatives
• Demand for rapid, field-ready diagnostics

Company Highlights:
• Abbott rolled out dual-target RDTs across high-burden countries.
• Roche added Liat-compatible arbovirus test panels for fast deployment.
• Thermo Fisher established mobile labs in the Caribbean with portable qPCR.
• Bio-Rad launched ELISA tools that distinguish between co-circulating flaviviruses.

Regional Insights:
• Asia-Pacific: Dengue and chikungunya dominate public testing programs.
• Latin America: Brazil, Colombia, and Peru invest in decentralized arbovirus labs.
• Africa: Surveillance rising for Rift Valley Fever and West Nile virus.
• North America/Europe: Focus on travel medicine and integrated vector surveillance.

For more insights, visit https://clearviewmarketinsights.com/

Media contact:
Bhavani K
Marketing and Sales Head
ClearView Market Insights
Mail: sales@clearviewmarketinsights.com
Phone: +1 917-993-7369

About Clearview Market Insights
Clearview Market Insights is a leading provider of global infectious disease diagnostics research, offering forward-looking insights across more than 100 disease surveillance and laboratory technology markets. We assist stakeholders in aligning innovation with public health priorities through data, forecasting, and strategic guidance.

This release was published on openPR.